OCRA’s Collaborative Research Development Grant is the organization’s largest and most prestigious grant mechanism, funding multi-investigator, team-based research projects focused on ovarian cancer and related gynecologic cancers. Interdisciplinary collaborations involving investigators from multiple institutions are encouraged. Priority research areas include screening and early detection, etiology and prevention, therapeutics development, and cancer biology and genetics. This year’s cycle is open internationally with no citizenship restrictions, and applications are managed through SmartSimple. OCRA is also partnering with Microsoft’s AI for Good Lab to provide in-kind Azure computing credits for projects with AI components.
Eligibility Criteria:
- Team of researchers required; one investigator designated as PI
- PI and all lead investigators must hold full-time faculty or equivalent appointments at accredited universities, medical schools, public health schools, or recognized non-profit research institutions
- No citizenship restrictions; international collaborations encouraged
- At least one key investigator must be a physician with expertise in ovarian or related gynecologic cancers
- Teams may be from same institution or multiple institutions
- Only one LOI submission per PI per grant cycle allowed
- Cannot currently hold an active OCRA grant (no concurrent awards)
Funding Details:
- Up to $300,000/year for 3 years ($900,000 total)
- Award is made to the PI’s institution
- Microsoft AI for Good Lab may provide additional in-kind Azure computing credits for AI-focused project components
- No for-profit institutions eligible
Deadline:
- LOI deadline: March 25, 2026, 5:00 PM Eastern Time (via SmartSimple — no extensions)
- All applicants notified of LOI status: mid-May 2026
- Full proposals (by invitation only): mid-June 2026
Where to Go for Further Information:
- RFP/LOI guidelines.
- Main grants page.
- Contact: grants@ocrahope.org.